Stock Market Update - July 20, 2026
Today's stock market saw some significant movers. Here's a breakdown of 5 stocks that caught our attention:
1. ZYBT - Zhengye Biotechnology Holding Limited
Price: $8.01 | Change: +1047.56% ($7.312)
ZYBT recently exploded with an incredible 1047.56% gain! Zhengye Biotechnology Holding Limited saw its stock price skyrocket around July 20-21, 2026, not due to a new company announcement or a boost in their core business.
Instead, this dramatic surge appears to be a classic case of speculative trading and momentum, particularly focused on its Nasdaq compliance. The stock had previously received a delisting warning for falling below the $1 minimum bid price. Its rapid climb back above this threshold fueled intense interest among traders, who saw potential for the company to regain compliance, despite recent weak financials. Trading volumes went through the roof, turning ZYBT into a highly volatile play.
What makes this move stand out is the disconnect between the massive price jump and the company's underlying performance, which includes declining revenue and a net loss for 2025. While Zhengye does have over $50 million in cash, this spectacular short-term rally was driven by the specific mechanics of avoiding delisting and the speculative frenzy it created, rather than fundamental business improvements.
2. ADVB - Advanced Biomed Inc. Common Stock
Price: $8.9 | Change: +76.94% ($3.87)
ADVB shot up an impressive 76.94% recently, primarily due to news about the termination of a $25 million equity agreement. Advanced Biomed Inc. (ADVB:NASDAQ) ended a deal with Helena Global Investment Opportunities that would have allowed the company to sell up to $25 million of its common stock over time. The interesting part? Advanced Biomed never actually used this facility to raise capital, beyond some initial fees.
The market gave a big thumbs-up to this move. Even though the agreement offered a potential source of future funding, investors seemed to focus on the removal of a different possibility: future dilution of shares. Essentially, the termination meant there was no longer the risk of new shares being issued, which can reduce the value of existing shares.
This decision by Advanced Biomed, despite not having announced a replacement financing plan, was seen as a win for current shareholders. It highlights how much value investors place on avoiding potential dilution, even when it means closing off a funding option.
3. GMM - Global Mofy Metaverse Limited
Price: $3.51 | Change: +37.11% ($0.95)
GMM just saw a notable 37.11% gain, catching investors' eyes around July 21, 2026. This upward movement appears driven by strong positive sentiment surrounding Global Mofy's generative AI content services and significant speculative interest. While no singular new announcement was made directly on this date, the stock's momentum has been building, continuing a positive market reaction to strategic advancements from May and June.
Global Mofy has been busy expanding its AI capabilities. Recent highlights include a development milestone for its generative AI platform, Gausspeed, built with NVIDIA Omniverse, and partnerships like the one with Shanghai Infinigence AI to develop an industrial-grade AIGC content creation platform. The company also applied to join the Snowflake Partner Network to enhance its digital content data capabilities.
It's important to note that a 1-for-50 reverse stock split on June 11, 2026, mechanically increased the share price and shouldn't be mistaken for a fundamental revaluation of the business. The current rise in July instead points to the market's strong interest and speculative response to Global Mofy's ongoing commitment to expanding its AI-driven content production capabilities.
4. LVLU - Lulu's Fashion Lounge Holdings, Inc.
Price: $16.62 | Change: +32.30% ($4.0576)
LVLU recently jumped an impressive 32.30% following a significant announcement. Lulu's Fashion Lounge Holdings, Inc. revealed that its Board of Directors has formed a special committee of independent directors. This committee is tasked with exploring "strategic alternatives" aimed at maximizing shareholder value.
What does that mean for investors? Essentially, this committee will evaluate various options, which could include a potential sale, merger, or acquisition of the company. While Lulu's has faced ongoing financial challenges and a history of losses, this proactive approach sparked investor optimism for a potential turnaround or restructuring. The news effectively put the company "in play," suggesting it could become an acquisition target, even though there's no guarantee any specific transaction will occur.
5. ONCO - Onconetix, Inc.
Price: $1 | Change: +31.54% ($0.2398)
ONCO (Onconetix, Inc.) recently experienced a significant 31.54% gain, capturing investor attention. This surge is largely due to the company's strategic pivot into AI-powered humanoid robotics, driven by its pending acquisition of Realbotix LLC. A key catalyst for the recent uptick was news detailing Realbotix's humanoid robots being featured in a live pre-standard 6G trial at Ericsson's U.S. headquarters, showcasing their advanced AI integration capabilities for cloud and network environments.
Further contributing to positive sentiment were Realbotix's recent partnerships, including a UK pilot program to utilize humanoid robots to combat social isolation among the elderly, and a pilot program for AI Teachers Assistants in New York schools. While the stock also underwent recent reverse splits for Nasdaq compliance, these events collectively underscore investor interest in Onconetix's bold move to re-establish itself squarely in the rapidly growing robotics and AI sectors.
This analysis was generated using AI and real-time stock data. Always do your own research before making investment decisions.